Developing safe and effective gene therapies by harnessing the power of engineering biology
Advancing healthcare by developing the next generation of controllable gene therapies: right location, level and time.
University of Edinburgh | Imperial College London | University of Oxford | Cancer Research UK (CRUK) Scotland Institute
UKRI Mission Hub
We develop safe and effective gene therapies for heart disease, cancer and rare diseases - harnessing engineering biology to create targeted, controllable treatments with minimal side effects.
Latest news
- Researchers develop new caffeine-responsive “genetic switch”
- 16 October, 2026
- From Research to Clinic: Training the Next Generation of Advanced Therapies Researchers
- 16 October, 2026
- Advanced Therapeutics Hub at Advanced Therapies Integrates North 2026
- 21 May, 2026
- UK-wide nucleic acid network launches to connect research, industry and innovation
- 21 May, 2026
- Engineering viruses to create vaccines: Best Poster win for Hub researcher
- 28 April, 2026
- 2026 WORLDSymposium Young Investigator Award success
- 16 January, 2026
- Recognition for Prof. Andy Baker through RSE Sir James Black medal
- 25 November, 2025
We want to partner with organisations who wish to increase adoption of advanced therapeutics, such as gene therapies, and shorten the pathway from lab to patient.
Partnership and collaboration are integral to our success. Our hub unites academic excellence across renowned institutions, each bringing unique expertise and strengths.
We are a ground-breaking engineering biology research initiative revolutionising the healthcare of patients living with life-limiting or life-threatening diseases - developing safe and effective advanced therapeutics.
This article was published on